THE PLASTIC SURGERY FOUNDATION
BIA-ALCL PROFILE Registry
(Patient Registry and Outcomes For breast Implants and anaplastic large cell Lymphoma etiology and Epidemiology) is a collaboration between ASPS, The PSF, and the FDA to better understand the role of breast implants in the etiology of anaplastic large cell lymphoma (ALCL) in order to determine whether an association exists between the device and the disease. Currently only open to physicians to report a case practicing in the United StatesAdditional information about PROFILE can be found on the following website
https://www.thepsf.org/research/registries/profile
AMERICAN SOCIETY OF PLASTIC SURGEONS
ASPS now recognizes approximately 903 both suspected and confirmed cases worldwide as of April 24, 2020.
https://www.plasticsurgery.org/for-medical-professionals/health-policy/bia-alcl-physician-resources
Research papers
Breast Implant–Associated Anaplastic Large Cell Lymphoma: Review and Multiparametric Imaging Paradigms
https://pubs.rsna.org/doi/10.1148/rg.2020190198
New guidelines for breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)
Mark Clemens, M.D, associate professor of Plastic Surgery, President of the 1st World Consensus Conference on BIA-ALCL – 02/03/2020
Breast implant-associated anaplastic large-cell lymphoma: first case detected in a Japanese breast cancer patient – published 24/02/2020
https://link.springer.com/article/10.1007/s12282-020-01064-5
Journal of Clinical Medicine — Open Access Journal
Incidence of Anaplastic Large Cell Lymphoma and Breast-Implant-Associated Lymphoma—An Analysis of a Certified Tumor Registry over 17 Years https://t.co/EKyLHev7wc?amp=1
Conferences
Annual Miami Breast Cancer Conference
Breast implant-associated anaplastic large cell lymphoma, symptoms, diagnosis and treatment
News
Allergan Faces Wrongful Death Lawsuit Over Breast Implant Lymphoma
ASPS now recognizes approximately 903 both suspected and confirmed cases worldwide as of April 24, 2020.
